Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori cell wall and membrane proteins and enzymes comprise a diverse set of bacterial components essential for the organism’s survival, colonization, and virulence within the human stomach. The cell wall is made primarily of peptidoglycan, whose synthesis and remodeling involve penicillin-binding proteins and specialized PG-modifying enzymes (e.g., Csd1, Csd3, Csd4, Csd6)[1][5]. The outer membrane contains a large and unusually diverse array of outer membrane proteins, divided into families such as Hop, Hor, Hof, Hom, iron-regulated proteins, and efflux pumps[2][4][6]. These include porins and adhesins (BabA, SabA), which mediate adhesion to gastric epithelial cells, as well as factors involved in immune evasion and pathogenesis (e.g., CagA delivered by the type IV secretion system)[4][9]. Structural proteins such as CcmA and MreB, and non-enzymatic scaffold proteins like Csd5 and Csd7, are vital for the maintenance of the bacterium’s helical cell shape, which is critical for gastric colonization[1][3][5][7]. These molecular constituents are established or emerging therapeutic targets for antibiotics and novel inhibitors, but the inherent genetic variability, redundancy, and the broad diversity of these proteins pose significant challenges for targeted drug development and resistance management. *Note: For precise drug or diagnostic targeting, it is necessary to specify the individual protein or enzyme (e.g., "Helicobacter pylori penicillin-binding protein 1A," "Helicobacter pylori outer membrane protein BabA") rather than refer to the entire group collectively.*
Inhibition of cell wall peptidoglycan biosynthesis (β-lactams, other PG enzyme inhibitors); Disruption of outer membrane integrity; Blocking adhesin binding to gastric mucosa (e.g., BabA, SabA antagonists); Inhibition of protein synthesis (ribosomal inhibitors)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell wall and membrane proteins and enzymes.